{"id":"https://openalex.org/W7205305201","doi":null,"title":"A first focus on the phase I biotransformation pathways followed by a selected set of bisphenol A alternatives","display_name":"A first focus on the phase I biotransformation pathways followed by a selected set of bisphenol A alternatives","publication_year":2026,"publication_date":"2026-05-13","ids":{"openalex":"https://openalex.org/W7205305201"},"language":"en","primary_location":{"id":"pmh:oai:HAL:hal-05626924v1","doi":null,"is_oa":true,"landing_page_url":"https://hal.science/hal-05626924v1","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"PARC WP5 Hazard assessment annual meeting, May 2026, Rome, Italy. 2026","raw_type":"info:eu-repo/semantics/conferenceObject"},"volume":null,"type":"conference-paper","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://hal.science/hal-05626924v1","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5118857018","display_name":"Louise Gutter","orcid":"https://orcid.org/0000-0001-9032-1665","observed_orcids":["https://orcid.org/0000-0001-9032-1665"]},"institutions":[{"id":"https://openalex.org/I4210100066","display_name":"Toxicologie Alimentaire","ror":"https://ror.org/0111a5077","country_code":"FR","type":"facility","lineage":["https://openalex.org/I176063091","https://openalex.org/I205747304","https://openalex.org/I4210088668","https://openalex.org/I4210089154","https://openalex.org/I4210100066","https://openalex.org/I4210117091","https://openalex.org/I4405258862"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"G\u00fctter, Louise","raw_affiliation_strings":["ToxAlim-MeX - M\u00e9tabolisme et X\u00e9nobiotiques (23 ch. Capelles 31076 TOULOUSE - France)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ToxAlim-MeX - M\u00e9tabolisme et X\u00e9nobiotiques (23 ch. Capelles 31076 TOULOUSE - France)","institution_ids":["https://openalex.org/I4210100066"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042821141","display_name":"Sandrine Bruel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100066","display_name":"Toxicologie Alimentaire","ror":"https://ror.org/0111a5077","country_code":"FR","type":"facility","lineage":["https://openalex.org/I176063091","https://openalex.org/I205747304","https://openalex.org/I4210088668","https://openalex.org/I4210089154","https://openalex.org/I4210100066","https://openalex.org/I4210117091","https://openalex.org/I4405258862"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Sandrine, Bruel","raw_affiliation_strings":["ToxAlim-MeX - M\u00e9tabolisme et X\u00e9nobiotiques (23 ch. Capelles 31076 TOULOUSE - France)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ToxAlim-MeX - M\u00e9tabolisme et X\u00e9nobiotiques (23 ch. Capelles 31076 TOULOUSE - France)","institution_ids":["https://openalex.org/I4210100066"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089753285","display_name":"Anne Hillenweck","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100066","display_name":"Toxicologie Alimentaire","ror":"https://ror.org/0111a5077","country_code":"FR","type":"facility","lineage":["https://openalex.org/I176063091","https://openalex.org/I205747304","https://openalex.org/I4210088668","https://openalex.org/I4210089154","https://openalex.org/I4210100066","https://openalex.org/I4210117091","https://openalex.org/I4405258862"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Hillenweck, Anne","raw_affiliation_strings":["ToxAlim-MeX - M\u00e9tabolisme et X\u00e9nobiotiques (23 ch. Capelles 31076 TOULOUSE - France)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ToxAlim-MeX - M\u00e9tabolisme et X\u00e9nobiotiques (23 ch. Capelles 31076 TOULOUSE - France)","institution_ids":["https://openalex.org/I4210100066"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067690579","display_name":"Sylvie Chevolleau","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138015","display_name":"MetaboHUB","ror":"https://ror.org/039gscz82","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I2738703131","https://openalex.org/I4210088668","https://openalex.org/I4210138015"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Chevolleau, Sylvie","raw_affiliation_strings":["E20 - Metatoul AXIOM (Analyse de X\u00e9nobiotiques, Identification, M\u00e9tabolisme, Plateforme de M\u00e9tabolomique et de Chimie Analytique en Toxicologie23 ch. Capelles 31076 TOULOUSE - France)","MetaboHUB-MetaToul (Regroupement de 4 plateformes technologiques et d\u2019expertises Toulouse - France)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"E20 - Metatoul AXIOM (Analyse de X\u00e9nobiotiques, Identification, M\u00e9tabolisme, Plateforme de M\u00e9tabolomique et de Chimie Analytique en Toxicologie23 ch. Capelles 31076 TOULOUSE - France)","institution_ids":[]},{"raw_affiliation_string":"MetaboHUB-MetaToul (Regroupement de 4 plateformes technologiques et d\u2019expertises Toulouse - France)","institution_ids":["https://openalex.org/I4210138015"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063525240","display_name":"Emilien L. Jamin","orcid":"https://orcid.org/0000-0002-4568-9177","observed_orcids":["https://orcid.org/0000-0002-4568-9177"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jamin, Emilien","raw_affiliation_strings":["E20 - Metatoul AXIOM (Analyse de X\u00e9nobiotiques, Identification, M\u00e9tabolisme, Plateforme de M\u00e9tabolomique et de Chimie Analytique en Toxicologie23 ch. Capelles 31076 TOULOUSE - France)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"E20 - Metatoul AXIOM (Analyse de X\u00e9nobiotiques, Identification, M\u00e9tabolisme, Plateforme de M\u00e9tabolomique et de Chimie Analytique en Toxicologie23 ch. Capelles 31076 TOULOUSE - France)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034149198","display_name":"Isabelle Jouanin","orcid":"https://orcid.org/0000-0002-2344-1840","observed_orcids":["https://orcid.org/0000-0002-2344-1840"]},"institutions":[{"id":"https://openalex.org/I4210138015","display_name":"MetaboHUB","ror":"https://ror.org/039gscz82","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I2738703131","https://openalex.org/I4210088668","https://openalex.org/I4210138015"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jouanin, Isabelle","raw_affiliation_strings":["E20 - Metatoul AXIOM (Analyse de X\u00e9nobiotiques, Identification, M\u00e9tabolisme, Plateforme de M\u00e9tabolomique et de Chimie Analytique en Toxicologie23 ch. Capelles 31076 TOULOUSE - France)","MetaboHUB-MetaToul (Regroupement de 4 plateformes technologiques et d\u2019expertises Toulouse - France)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"E20 - Metatoul AXIOM (Analyse de X\u00e9nobiotiques, Identification, M\u00e9tabolisme, Plateforme de M\u00e9tabolomique et de Chimie Analytique en Toxicologie23 ch. Capelles 31076 TOULOUSE - France)","institution_ids":[]},{"raw_affiliation_string":"MetaboHUB-MetaToul (Regroupement de 4 plateformes technologiques et d\u2019expertises Toulouse - France)","institution_ids":["https://openalex.org/I4210138015"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5148978153","display_name":"Daniel Zalko","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100066","display_name":"Toxicologie Alimentaire","ror":"https://ror.org/0111a5077","country_code":"FR","type":"facility","lineage":["https://openalex.org/I176063091","https://openalex.org/I205747304","https://openalex.org/I4210088668","https://openalex.org/I4210089154","https://openalex.org/I4210100066","https://openalex.org/I4210117091","https://openalex.org/I4405258862"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Zalko, Daniel","raw_affiliation_strings":["ToxAlim-MeX - M\u00e9tabolisme et X\u00e9nobiotiques (23 ch. Capelles 31076 TOULOUSE - France)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ToxAlim-MeX - M\u00e9tabolisme et X\u00e9nobiotiques (23 ch. Capelles 31076 TOULOUSE - France)","institution_ids":["https://openalex.org/I4210100066"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10686","display_name":"Effects and risks of endocrine disrupting chemicals","score":0.98580002784729,"subfield":{"id":"https://openalex.org/subfields/2307","display_name":"Health, Toxicology and Mutagenesis"},"field":{"id":"https://openalex.org/fields/23","display_name":"Environmental Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10686","display_name":"Effects and risks of endocrine disrupting chemicals","score":0.98580002784729,"subfield":{"id":"https://openalex.org/subfields/2307","display_name":"Health, Toxicology and Mutagenesis"},"field":{"id":"https://openalex.org/fields/23","display_name":"Environmental Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.005799999926239252,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10122","display_name":"Toxic Organic Pollutants Impact","score":0.002899999963119626,"subfield":{"id":"https://openalex.org/subfields/2307","display_name":"Health, Toxicology and Mutagenesis"},"field":{"id":"https://openalex.org/fields/23","display_name":"Environmental Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bisphenol-a-alternatives","display_name":"bisphenol A alternatives","score":0.9559999704360962},{"id":"https://openalex.org/keywords/phase-i-biotransformation","display_name":"phase I biotransformation","score":0.8659999966621399},{"id":"https://openalex.org/keywords/cyp450-isoforms","display_name":"CYP450 isoforms","score":0.7599999904632568},{"id":"https://openalex.org/keywords/metabolic-activation","display_name":"metabolic activation","score":0.4300000071525574},{"id":"https://openalex.org/keywords/heparg-cells","display_name":"HepaRG cells","score":0.9490000009536743},{"id":"https://openalex.org/keywords/phase-ii-conjugation","display_name":"phase II conjugation","score":0.5979999899864197},{"id":"https://openalex.org/keywords/bisphenol-analogues","display_name":"bisphenol analogues","score":0.47600001096725464},{"id":"https://openalex.org/keywords/endocrine-disruptors","display_name":"endocrine disruptors","score":0.7459999918937683}],"concepts":[{"id":"https://openalex.org/C192209626","wikidata":"https://www.wikidata.org/wiki/Q190909","display_name":"Focus (optics)","level":2,"score":0.7034000158309937},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5831999778747559},{"id":"https://openalex.org/C177264268","wikidata":"https://www.wikidata.org/wiki/Q1514741","display_name":"Set (abstract data type)","level":2,"score":0.5623000264167786},{"id":"https://openalex.org/C2779684741","wikidata":"https://www.wikidata.org/wiki/Q271980","display_name":"Bisphenol A","level":3,"score":0.5342000126838684},{"id":"https://openalex.org/C27881333","wikidata":"https://www.wikidata.org/wiki/Q864895","display_name":"Biotransformation","level":3,"score":0.49889999628067017},{"id":"https://openalex.org/C44280652","wikidata":"https://www.wikidata.org/wiki/Q104837","display_name":"Phase (matter)","level":2,"score":0.4884999990463257},{"id":"https://openalex.org/C183696295","wikidata":"https://www.wikidata.org/wiki/Q2487696","display_name":"Biochemical engineering","level":1,"score":0.34389999508857727},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.32829999923706055},{"id":"https://openalex.org/C204241405","wikidata":"https://www.wikidata.org/wiki/Q461499","display_name":"Transformation (genetics)","level":3,"score":0.28940001130104065},{"id":"https://openalex.org/C2779848963","wikidata":"https://www.wikidata.org/wiki/Q424197","display_name":"Bisphenol","level":3,"score":0.25519999861717224}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:HAL:hal-05626924v1","doi":null,"is_oa":true,"landing_page_url":"https://hal.science/hal-05626924v1","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"PARC WP5 Hazard assessment annual meeting, May 2026, Rome, Italy. 2026","raw_type":"info:eu-repo/semantics/conferenceObject"}],"best_oa_location":{"id":"pmh:oai:HAL:hal-05626924v1","doi":null,"is_oa":true,"landing_page_url":"https://hal.science/hal-05626924v1","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"PARC WP5 Hazard assessment annual meeting, May 2026, Rome, Italy. 2026","raw_type":"info:eu-repo/semantics/conferenceObject"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.6240000128746033}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7223078846","https://openalex.org/W7104056256","https://openalex.org/W4317938327","https://openalex.org/W3012674653","https://openalex.org/W7163667433","https://openalex.org/W7126757955","https://openalex.org/W1987554735","https://openalex.org/W4403638843","https://openalex.org/W4317207863","https://openalex.org/W4414076828"],"abstract_inverted_index":{"Bisphenol":[0],"A":[1],"(BPA)":[2],"is":[3,29],"widely":[4],"used":[5],"in":[6,76,95,112,179,215,226],"the":[7,106,113,169,180,184,197,216,228,249],"production":[8],"of":[9,56,85,117,138,146,172,183,199,248,259],"polycarbonate":[10],"plastics":[11],"and":[12,22,26,43,64,98,141,160,194,213,233,251],"epoxy":[13],"resins,":[14],"to":[15,104,136,144,167,243,252,271],"manufacture":[16],"numerous":[17],"consumer":[18],"products":[19],"including":[20,41,149],"food":[21],"beverage":[23],"containers,":[24],"lacquers":[25],"coatings.":[27],"BPA":[28,49,86,186,260],"a":[30,82,245,255],"well-studied":[31],"endocrine":[32],"disruptor":[33],"with":[34],"potential":[35,65],"adverse":[36],"effects":[37],"on":[38],"human":[39,78,128],"health,":[40],"reproductive":[42],"metabolic":[44,62,100,181,265],"disorders.":[45],"Conversely,":[46],"for":[47,81,133,210,230],"many":[48],"alternatives,":[50],"there":[51],"remain":[52],"major":[53],"data":[54,73,242],"gaps":[55],"knowledge,":[57],"notably":[58],"as":[59],"regards":[60],"their":[61,264],"fate":[63,182],"bioactivation":[66],"pathways.In":[67],"this":[68],"study,":[69],"we":[70,102],"present":[71],"novel":[72],"obtained":[74],"using":[75,127],"vitro":[77],"hepatic":[79],"models":[80],"first":[83],"set":[84],"alternatives":[87,187],"prioritized":[88],"within":[89],"PARC.":[90],"Following":[91],"full":[92],"mass-balance":[93],"studies":[94],"HepaRG":[96],"cells":[97],"radio-HPLC":[99,166],"profiling,":[101],"started":[103],"explore":[105],"specific":[107],"cytochromes":[108],"P450":[109],"isoforms":[110],"involved":[111,218],"phase":[114,200,204],"I":[115,205],"biotransformation":[116],"BPAP,":[118,139],"BPE,":[119,140],"BPZ,":[120,142],"TBBPA,":[121],"TCBPA,":[122],"by":[123,165],"screening":[124],"these":[125,267],"activities":[126],"CYP-recombinant":[129],"supersomes.Supersomes":[130],"were":[131,162,208,219],"exposed":[132],"30":[134],"minutes":[135],"12.5pmol":[137],"or":[143],"1nmol":[145],"halogenated":[147],"bisphenols,":[148],"2.5":[150],"kBq/molecule.":[151],"All":[152],"experiments":[153],"included":[154],"negative":[155],"controls.":[156],"Radioactivity":[157],"was":[158],"counted":[159],"supernatants":[161],"individually":[163],"analysed":[164],"assess":[168],"CYP450-dependant":[170],"formation":[171],"metabolites.":[173],"Current":[174],"results":[175],"demonstrate":[176],"notable":[177],"differences":[178,214],"different":[185],"assayed,":[188],"both":[189],"quantitatively":[190],"(global":[191],"metabolization":[192],"rate)":[193],"qualitatively.":[195],"Despite":[196],"predominance":[198],"II":[201],"conjugation":[202],"pathways,":[203],"oxidative":[206],"pathways":[207],"evidenced":[209],"several":[211],"substances,":[212],"XMEs":[217],"also":[220,269],"highlighted.":[221],"Next":[222],"steps":[223],"will":[224],"consist":[225],"completing":[227],"assays":[229],"additional":[231],"substances":[232],"characterize":[234],"associated":[235],"enzymatic":[236],"constants.":[237],"These":[238],"findings":[239],"provide":[240],"critical":[241],"achieve":[244],"better":[246,256],"characterization":[247],"hazards,":[250],"progress":[253],"towards":[254],"risk":[257],"assessment":[258],"substitutes.":[261],"By":[262],"elucidating":[263],"fate,":[266],"researches":[268],"contribute":[270],"regulatory":[272],"assessments.":[273]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-09-02T00:00:00"}